Log In
BCIQ
Print this Print this
 

MERS-CoV vaccine

  Manage Alerts
Collapse Summary General Information
Company Novavax Inc.
DescriptionMERS-CoV vaccine directed against the surface spike protein and formulated using recombinant nanoparticle vaccine technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationCoronavirus
Indication DetailsVaccinate against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today